ÖZSOY, Z. Et Al. 2023. Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?. Rheumatology International , vol.43, no.8 , 1445-1451.

ÖZSOY, Z., ÖZDEMİR, A., EKİCİ, M., BİLGİN, E., KILIÇ, L., KİRAZ, S., ... SARIBAŞ, Z.(2023). Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?. Rheumatology International , vol.43, no.8, 1445-1451.

ÖZSOY, ZEHRA Et Al. "Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?," Rheumatology International , vol.43, no.8, 1445-1451, 2023

ÖZSOY, ZEHRA Et Al. "Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?." Rheumatology International , vol.43, no.8, pp.1445-1451, 2023

ÖZSOY, Z. Et Al. (2023) . "Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?." Rheumatology International , vol.43, no.8, pp.1445-1451.

@article{article, author={ZEHRA ÖZSOY Et Al. }, title={Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?}, journal={Rheumatology International}, year=2023, pages={1445-1451} }